Publications
- Fecal microbiota transplantation - new possibility to influence the results of therapy of cancer patients2022 | First Faculty of Medicine, Second Faculty of Medicine
- New methodology of TMB assessment from tissue and liquid biopsy in NSCLC2022 | First Faculty of Medicine
- Pembrolizumab as a first-line therapy in spinocellular esophageal cancer2021 | First Faculty of Medicine
- Future of lung cancer treatment2021 | First Faculty of Medicine
- Mitochondrially targeted tamoxifen in patients with metastatic solid tumours: an open-label, phase I/Ib single-centre trial2023 | First Faculty of Medicine, Third Faculty of Medicine, Central Library of Charles University, Faculty of Science, Faculty of Mathematics and Physics
- Mitochondrially targeted tamoxifen as anticancer therapy: case series of patients with renal cell carcinoma treated in a phase I/Ib clinical trial2023 | First Faculty of Medicine, Third Faculty of Medicine, Central Library of Charles University, Faculty of Science, Faculty of Mathematics and Physics
- Microbiota as the unifying factor behind the hallmarks of cancer2023 | First Faculty of Medicine
- Přínos sekvenování nové generace v terapii nemalobuněčného plicního karcinomu - zaměřeno na rezistence u EGFR mutovaného nemalobuněčného plicního karcinomu2023 | First Faculty of Medicine
- Radiation-Induced Lymphopoenia and Treatment Outcome in Hereditary Breast Cancer Patients2023 | First Faculty of Medicine
- Molecularly targeted treatment and the principle of agnostic therapy2022 | First Faculty of Medicine
Loading network view...